The R&D lab smelled like ozone and ambition.
I stood before a holographic display showing molecular structures that shouldn't exist yet—wouldn't exist for another year if Aldrich Killian followed his original timeline. Extremis. The biological enhancement that could heal catastrophic injuries or turn people into walking bombs depending on who designed it.
I was betting everything on "or."
"Run the simulation again," I told AEGIS. "Focus on thermal cascade prevention."
The display shifted, showing cellular interaction patterns. Maya Vasquez leaned against the workbench beside me, arms crossed, expression skeptical.
"This is the third variation you've designed without testing," she said. "Either you're incredibly confident or you know something I don't."
"Advanced probability modeling."
"Bullshit. Nobody designs biological enhancement protocols this quickly through modeling alone. You're skipping steps that should take months."
I pulled up Chitauri tissue samples we'd recovered during cleanup operations. "These samples show regenerative properties beyond anything human biology produces. Healing factors that operate at cellular level without thermal buildup. If we can isolate the mechanism—"
"We can create controllable enhancement. I know the theory." Maya pulled up her own data. "But you're combining Chitauri regeneration with extremophile bacteria proteins in ways that shouldn't work. Yet every simulation suggests they will. How?"
"Scientific Intuition."
"Your mutation lets you understand technology, not predict biochemical interactions you've never tested."
She wasn't wrong. Scientific Intuition gave me comprehension, not precognition. But I couldn't explain that I'd seen Killian's mistakes, knew exactly which pathways led to explosive failure, understood the precise modifications needed to prevent thermal cascade.
"Call it educated guessing," I said. "I've reviewed every biological enhancement attempt in recorded history. Analyzed failure patterns. Predicted common mistakes. This design accounts for those mistakes before we make them."
Maya studied me. "You're lying."
"I'm simplifying."
"That's not the same as being honest."
"Would you prefer honesty that sounds insane?"
She was quiet. Then: "Try me."
I met her eyes. "I can't. Not because I don't trust you, but because the truth would make you a target. Some knowledge is dangerous to possess."
"More dangerous than developing biological enhancement that could turn people into explosives if we get it wrong?"
"Yes."
"Jesus, Justin." She rubbed her face. "Fine. Keep your secrets. But if this blows up—literally—I'm putting 'I told you so' on your headstone."
"Fair enough."
The first test subject was a lab mouse named Prometheus.
Standard white mouse, three years old, suffering from cancer that would kill him within weeks. Perfect candidate for regenerative therapy. Maya injected the modified serum while I monitored via holographic display.
"Injection complete," she said. "Compound entering bloodstream. Cellular uptake beginning... now."
The mouse's vitals spiked. Heart rate increased. Temperature rose five degrees. I held my breath.
This is the critical moment. Where Killian's version would cascade into thermal explosion.
But the temperature stabilized at 103 degrees. The mouse's tumor began shrinking visibly on the scan. Cancer cells dying, healthy tissue regenerating, all without the catastrophic cellular rejection that defined Extremis failures.
"Temperature holding," AEGIS reported. "Regeneration rate: two hundred percent above baseline. No thermal runaway detected. Cellular integrity maintained."
Maya stared at the monitors. "That's... that's impossible. First-trial success never happens with biological enhancement."
"It does when you account for every failure mode before testing."
"Or when you already know the solution." She turned to me. "This isn't probability modeling. This is too precise. Too fast. You designed this serum like you'd already seen it fail and knew exactly how to fix it."
I didn't answer. Just watched Prometheus the mouse scurry around his cage, cancer-free and energetic, while regeneration continued healing age-related damage.
"How long will it last?" Maya asked quietly.
"Seventy-two hours before natural death from old age. But the enhancement will remain stable until then. No thermal spikes. No cellular rejection. Clean regeneration."
"And for humans?"
"Six to eight months before trials if we follow proper protocols. Maybe faster if we accept higher risk."
"We follow protocols," Maya said firmly. "I won't have another Weapon X situation where we rush and create monsters."
"Agreed."
She collected samples while I reviewed data. Successful first test. Stable enhancement. Proof of concept achieved. But Prometheus was just a mouse—human trials would reveal complications I couldn't predict even with future knowledge.
"Why now?" Maya asked, still working. "Why biological enhancement? We have enhanced operatives through other methods. Why push into unstable territory?"
I thought about Natasha facing threats that could tear her apart. About Yelena fighting HYDRA facilities. About ARES Division operatives who'd survive longer with regeneration factors.
"Because the threats are escalating," I said. "Chitauri invasion was just the beginning. Next crisis will be worse. And the one after that, worse still. I need every advantage possible."
"For yourself or for them?"
"Both."
Maya was quiet for a long moment. Then: "The void corruption. You're dying."
"Transforming. Different thing."
"Is it?" She sealed the samples. "Because from where I'm standing, you're racing against a deadline. Collecting powers. Developing enhancements. Building an empire. All before whatever's happening to you completes."
"That's the plan."
"Then let me help. Actually help, not just follow orders." She faced me fully. "I know you're hiding things. I know there's more to your strategic decisions than you admit. But I also know you're trying to save people. So use me properly—let me be more than just a suspicious engineer executing designs I don't fully understand."
I considered that. Maya was brilliant. Trustworthy. Observant enough to see through my bullshit but loyal enough not to sabotage operations. Maybe it was time to expand her clearance.
"Project Phoenix," I said. "That's what we're calling this. Biological enhancement without catastrophic failure. Your role is lead researcher with full authority over testing protocols, safety measures, and trial progression. I provide theoretical framework and strategic direction. You execute with medical rigor."
"And when I find inconsistencies in your theories?"
"Challenge them. I'm not infallible—just educated. Your skepticism keeps us honest."
Maya nodded slowly. "Okay. I can work with that." She pulled up new displays. "First priority: establishing ethical framework. Human trials require volunteer subjects, full informed consent, psychological screening, immediate termination procedures if instability detected. I'm not running a human experimentation lab."
"Neither am I. Draft the protocols. Make them airtight. We do this right or not at all."
"Why does this feel personal?" she asked. "Like you're not just developing military enhancement but protecting specific people?"
"Because I am. People I care about will face things that should kill them. I'd rather they survive."
"Natasha."
"Among others. Yelena. Frank. Anyone who puts themselves in danger because of missions I've authorized." I met her eyes. "I'm building an organization that continues after I'm gone. That means keeping key personnel alive longer than probability suggests they should be."
Maya studied me, then smiled slightly. "You're a terrible liar about emotions. You pretend it's all strategic, but you actually care. That's your weakness."
"Is it?"
"Or maybe your strength. Still deciding." She saved the protocols. "I'll have preliminary ethical framework ready by end of week. In the meantime—more tests with Prometheus and his friends. If we maintain stability across multiple subjects, we move to larger mammals."
"Agreed."
Late that night, I sat alone in my office reviewing Aldrich Killian's timeline.
AEGIS projected dates across holographic displays: Killian wouldn't begin human trials until mid-2013. Wouldn't perfect the formula until late 2013. Wouldn't create stable subjects until early 2014—and even then, stability would be temporary before Mandarin crisis forced desperate measures.
I had a year-long advantage. Maybe more.
But accelerating technology also accelerated attention. Extremis would draw interest from military contractors, intelligence agencies, criminal organizations, and HYDRA cells looking for enhanced soldiers.
The question: how to develop breakthrough enhancement while avoiding becoming target?
"Sir," AEGIS said quietly. "Probability analysis suggests Project Phoenix will attract hostile acquisition attempts within six months of first stable human subject. Recommendation: prepare defensive measures now."
"Already planning them. Decoy research programs. False leads. Misdirection about actual capabilities." I pulled up security protocols. "Also, restrict knowledge of success to inner circle only. Public narrative is 'experimental regenerative medicine in early testing'—not 'super soldier serum ready for deployment.'"
"Noted. Additional concern: Aldrich Killian's existing research timeline. If he achieves breakthrough independently while you're developing in parallel, he may attribute your success to corporate espionage."
"Let him. I'll prove independent development through published research that predates his by months." I thought for a moment. "Actually, better idea—recruit him before he spirals. Guy's brilliant but damaged. If I offer partnership instead of letting him create bombs, everyone wins."
"Recruitment probability?"
"Low. His vendetta against Tony Stark is personal and deep. But worth attempting."
I filed that idea for later consideration and returned to immediate concerns. Project Phoenix showed promise. Prometheus the mouse was healing nicely. Human trials were six to eight months away.
And somewhere in Sokovia, twins were preparing to accept HYDRA's enhancement. Somewhere in Russia, Ivan Vanko was beginning his redemption arc. Somewhere in Eastern Europe, forty Widows remained enslaved.
So many threads. So many people to save or fail to save.
The void marks pulsed beneath my shirt—nine percent corruption. Four years until transformation, maybe less.
Better make them count.
Note:
Read the raw, unfiltered story as it unfolds. Your support makes this possible!
👉 Find it all at patreon.com/Whatif0
Timeline Viewer ($6): Get 10 chapters of early access + 5 new chapters weekly.
Timeline Explorer ($9): Jump 15-20 chapters ahead of everyone.
Timeline Keeper ($15): Get Instant Access to chapters the moment I finish writing them. No more waiting.